Lina Gu

机构：Hebei Medical University, Hebei University of Economics and Business, Harbin Medical University, Hebei University of Science and Technology, Third Affiliated Hospital of Harbin Medical University, Fourth Hospital of Hebei Medical University, Yangzhou University, Cytori Therapeutics (United States) · ORCID：0000-0001-7787-0678

发表论文 87 篇 · 总被引 2182 次 · h-index 27

代表论文

• circCYP24A1 facilitates esophageal squamous cell carcinoma progression through binding PKM2 to regulate NF-κB-induced CCL5 secretion (2022 · Molecular Cancer · 被引 74)
• Circular RNA circWWC3 augments breast cancer progression through promoting M2 macrophage polarization and tumor immune escape via regulating the expression and secretion of IL-4 (2022 · Cancer Cell International · 被引 57)
• Hypoxia inducible factor 1α inhibitor PX-478 reduces atherosclerosis in mice (2022 · Atherosclerosis · 被引 39)
• Circular RNA circ‐TNRC6B inhibits the proliferation and invasion of esophageal squamous cell carcinoma cells by regulating the miR ‐452‐5p/ DAG1 axis (2023 · Molecular Oncology · 被引 36)
• MRI radiomics in overall survival prediction of local advanced cervical cancer patients tread by adjuvant chemotherapy following concurrent chemoradiotherapy or concurrent chemoradiotherapy alone (2022 · Magnetic Resonance Imaging · 被引 18)
• Mesenchymal stem cell-derived extracellular vesicles alleviate cervical cancer by delivering microRNA-331-3p to reduce LIM zinc finger domain containing 2 methylation in tumor cells (2022 · Human Molecular Genetics · 被引 17)